tiprankstipranks
TipRanksStock Market NewsALNA NewsAnalysts Offer Insights on Healthcare Companies: Oncternal Therapeutics (ONCT), Allena Pharmaceuticals (ALNA) and Gritstone Oncology (GRTS)
Blurbs

Analysts Offer Insights on Healthcare Companies: Oncternal Therapeutics (ONCT), Allena Pharmaceuticals (ALNA) and Gritstone Oncology (GRTS)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Oncternal Therapeutics (ONCTResearch Report), Allena Pharmaceuticals (ALNAResearch Report) and Gritstone Oncology (GRTSResearch Report) with bullish sentiments.

Oncternal Therapeutics (ONCT)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Oncternal Therapeutics today and set a price target of $9.00. The company’s shares closed last Tuesday at $2.34.

According to TipRanks.com, Selvaraju ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -18.5% and a 25.2% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Aquestive Therapeutics, Inovio Pharmaceuticals, and Vallon Pharmaceuticals.

Oncternal Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $9.00.

See the top stocks recommended by analysts >>

Allena Pharmaceuticals (ALNA)

H.C. Wainwright analyst Edward White maintained a Buy rating on Allena Pharmaceuticals today and set a price target of $11.00. The company’s shares closed last Tuesday at $0.58.

According to TipRanks.com, White is a 4-star analyst with an average return of 8.9% and a 36.7% success rate. White covers the Healthcare sector, focusing on stocks such as Spectrum Pharmaceuticals, Silverback Therapeutics, and Karyopharm Therapeutics.

Allena Pharmaceuticals has an analyst consensus of Moderate Buy, with a price target consensus of $7.50.

Gritstone Oncology (GRTS)

H.C. Wainwright analyst Sean Lee CFA maintained a Buy rating on Gritstone Oncology today and set a price target of $24.00. The company’s shares closed last Tuesday at $7.02, close to its 52-week low of $3.00.

According to TipRanks.com, CFA is a 2-star analyst with an average return of 3.1% and a 26.9% success rate. CFA covers the Healthcare sector, focusing on stocks such as Monopar Therapeutics Inc, ThermoGenesis Holdings, and CASI Pharmaceuticals.

Currently, the analyst consensus on Gritstone Oncology is a Moderate Buy with an average price target of $17.50.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on ONCT:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More